The Lancet Haematology
Fecha de publicación: 06 june 2018
DOI: https://doi.org/10.1016/S2352-3026(18)30063-2
Autores: Prof Ingrid Pabinger, MD., Nick van Es, MD., Georg Heinze, PhD., Florian Posch, MD., Julia Riedl, MD., Eva-Maria Reitter, MD., Marcello Di Nisio, MD., Gabriela Cesarman-Maus, MD., Noémie Kraaijpoel, MD,. Prof Christoph Carl Zielinski, MD., Prof Harry Roger Büller, MD., Cihan Ay, MD.
Background: Venous thromboembolism is a common complication of cancer, but the risk of developing venous thromboembolism varies greatly among individuals and depends on numerous factors, including type of cancer. We aimed to develop and externally validate a clinical prediction model for cancer-associated venous thromboembolism.
Comentarios
Para dejar un comentario antes debes iniciar sesión:
¿No tienes una cuenta?
Regístrate a través de éste enlace.